framework growth
net dbt
appeal growth outlook rais estimates/po
bullish tone compani beat consensu estim rais guidanc
beat expect continu govern growth notabl
compani prepar provid headwind tailwind head next year
headwind pdp prescript drug membership declin due competit
also restrain pbm pharmaci benefit manag servic earn lower tricar
segment profit y/i due average result favor true up tailwind
fl medicaid contract roll busi momentum hc servic growth
annual knd result own clinic improv signific flexibl
report broad rang ep depend much hif want
keep estim ep reason target impli
stock trade ep line averag despit better near-term
long-term catalyst addit consensu low end rang indic
potenti upsid estim rais estim rais po roll
forward valuat metric new po base ep vs
prior estimate reiter buy rate continu strength
overal compani indic see strong result trend guidanc
assum portion favor persist impli guidanc
fischbeck focu could report
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu initi bridg bullish tone
growth outlook compani expect grow well lt ep
growth target quit broad rang potenti outcom lay
case ep driven momentum temporari hif
suspens number tailwind mco typic provid conserv initi
guidanc beat/rais walk estim throughout year would
surpris see provid initi guidanc rang weve laid
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest manag care
organ unit state offer health
insur member govern
commerci segment compani focu
medicar advantag also particip
govern program includ tricar
medicaid compani also commerci
busi offer medic specialti product
strong player fastest grow
market coverag number catalyst
repo creat signific upsid potenti
estim risk upsid includ potenti
share repurchas sever non-healthcar
rate potenti hif repeal
fischbeck focu earli bridg
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu initi bridg bullish tone
growth outlook compani expect grow well lt ep
growth target quit broad rang potenti outcom lay
case ep driven momentum temporari hif
suspens number tailwind mco typic provid conserv initi
guidanc beat/rais walk estim throughout year would
surpris see provid initi guidanc rang weve laid
could earn ep
bullish tone growth outlook compani expect grow
well lt ep growth target outlin number driver
think could push ep growth
ep line guidanc like conserv given
out-performance ytd low trend environ
elev flu season medic loss ratio neg affect
increment flu expens beyond typic flu season estim
headwind adjust arriv adjust
group/specialti year date benefit prior period
develop group/specialti segment assum compani get
net benefit year would repres tailwind
adjust arriv adjust baselin would expect
recur note compani includ amount
retail busi dont adjust amount
busi perform assum rang core busi
growth adjust baselin arriv growth
non-deduct hif suspens boost assum non-
deduct hif boost flow bottom line rest built
benefit would impli tailwind
ep estim could see ep
repres growth y/i well target lt rang howev
note mco typic provid conserv initi guidanc beat/rais
walk estim throughout year would surpris see
provid guidanc well rang weve laid
medicar advantag set nice
highlight favor environ driven strong rate
notic hif suspens gener medicar busi momentum
hif temporarili suspend recal hif suspend
exclud benefit approxim adjust ep relat
fact pass elimin hif back benefit pass
non-tax deduct portion let fall bottom line
continu target pre-tax margin without hif tax
lower ep benefit would closer think
compani like let benefit fall bottom line
indic may build back benefit design balanc
margin growth
flow bottom line
expect mid-teen group growth group still growth driver
expect less robust pipelin group vs mid-teen growth
howev still earli busi still nice growth driver hum
core busi addit think could present margin opportun
new member typic start lower margin
evalu growth option medicaid
hum recent statewid award florida compani expect serv
addit member exist medicaid membership view
estim conserv estim could add nearli ep
final evalu length time scale potenti barrier entri
state level compani appear open opportun space think
medicaid right price would well receiv would improv
posit dual elig popul
mco gener keep gross benefit tax reform reinvest
remain remind report anticip gross tax reform
benefit ep half spent invest growth
invest turn tailwind compani outspend peer benefit
enhanc growth driver posit well
chart report tax reform benefit kept mco
hc servic exposur grow
busi perform rel consist prior
expect pharmaci busi see lower expect
util lower util off-set higher expect mail order
penetr especi busi result pharmaci overal perform
line well
go forward see opportun test learn number market
focu prevent care avoid higher cost road overal expect
busi grow nice note compani believ clinic
busi move loss posit ebitda contribut
expect continu declin prescript drug pdp membership
recal note wal-mart pdp plan longer cheapest
plan number market mco price aggress assum
membership declin y/i margin compress estim
could headwind ep addit highlight pdp busi
impact pharmaci busi fact busi like sourc
margin compress view impact manag especi think
like off-set strong growth trajectori
tabl potenti impact pdp membership declin
also expect lower tricar profit group/specialti segment given
posit final settlement receiv relat prior contract
recur howev minim earn exposur aso-typ product
also view headwind quit manag compani quantifi
benefit seem like rang view
conclus tailwind clearli outweigh headwind
becom clear hum tailwind outweigh headwind see
signific upsid potenti estim month come estim
ep impli stock trade ep line
averag despit better near-term long-term catalyst addit consensu
low end rang indic potenti upsid estim reiter
buy rate continu execut strategi
ep guidanc lower expect
howev adjust ep guidanc rais beat
rais versu consensu beat expect approxim
driven oper perform retail segment partial off-set
perform segment includ recent
kindr deal compani note expect
retail pre-tax incom guidanc increas million midpoint driven
reduct retail guidanc show continu favor inpati
util trend busi outlook group specialti pre-tax incom
remain unchang million guidanc rais
driven impact reinsur transact lower premium
result hum commerci risk adjust accrual relat aca-compli
busi meanwhil pre-tax incom lower
million howev compani also provid adjust ebitda guidanc billion
midpoint note measur enhanc transpar result
increas group specialti segment revenu million
million midpoint re-affirmed revenu outlook retail segment
segment meanwhil compani maintain membership
outlook individu group medicar stand-alon pdp segment
tax rate guidanc lower expect
addit compani still expect core trend oper cash flow
guidanc lower million million midpoint capital-expenditure
outlook re-affirmed
relat compani guid headwind tailwind headwind
pdp membership declin due competit also restrain pbm servic
earn lower tricar segment profit y/i due average result
insur fee hif moratorium fl medicaid contract roll busi
momentum hc servic growth annual knd result own clinic
improv compani expect improv margin
get target margin next year expect meaning ep growth
lt growth target stop short say hif
benefit ad lt target rang
group specialti segment
chang year end medic membership prior year end
group specialti segment
group specialti segment
weight averag share count dilut ep
flow oper
chang mid
po base ep estim premium histor
averag justifi strong growth trajectori expect core
upsid risk potenti share repurchas sever non-healthcar catalyst
includ tax reform higher interest rate potenti hif repeal downsid risk
regular industri sensit point cost trend rate well unknown
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
